
Another trial of an experimental HIV vaccine has been halted after researchers concluded the vaccine provided only limited protection. The trial in five sub-Saharan African countries was launched in 2017 to assess the Johnson & Johnson HIV vaccine in over 2,000 young women at high risk of HIV infection. This is the latest in a… read on > read on >